Lactiplantibacillus plantarum strains KABP011, KABP012 and KABP013 modulate bile acids and cholesterol metabolism in humans.

The intervention with Lactiplantibacillus plantarum strains induces beneficial effects on BA signature and lipoprotein profile. It reduces ApoB and small-LDL levels and LDL susceptibility to oxidation, and increases HDL antioxidant capacity. These metabolic profile changes suggest increased protection against atherosclerotic disease.